Drug
Iohexol clinical trials
Also written Omnipaque.
- studies test it
- 18
- open now
- 3
- in phase 3
- 2
- first study started
- 2007
Keep track of what changes. Save the Iohexol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
18 studies that test it; most in 2020 (3)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 4
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 3
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
- Pain
- 1
Who runs them
Industry 4 · Other 14
Centre Hospitalier Universitaire de Saint Etienne (2) · NRG Oncology (1) · University Hospital, Angers (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Assistance Publique - Hôpitaux de Paris (1) · University Hospital, Tours (1) · MediBeacon (1) · University of Nebraska (1)
Often tested with
Tested in the same studies.
Carboplatin (1) · Relmapirazin (1) · Abemaciclib (1) · Metformin (1) · Dolutegravir (1) · Lidocaine (1) · Methylprednisolone (1) · Saline Solution (1)
Studies
Open first, then newest update. How each study uses Iohexol is read from its arms, and is right about nine times in ten.
Testing it · 18
- Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) BlockRecruitingNot applicableUniversity Hospitals Cleveland Medical CenterNCT07174440Written as Iohexol
- Development of a Bayesian Estimator for Calculating Plasma Iohexol ClearanceNot yet recruitingPhase 1Centre Hospitalier Universitaire de Saint EtienneNCT05136963Written as Iohexol
- Ultrasound-guided LMBB by Caudal-cranial Approach: Radiographic Comparison of a New Ultrasound-guided MethodRecruitingNot applicableErasme University HospitalNCT05930236Written as Omnipaque
- Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent IohexolActive, not recruitingPhase 1NRG OncologyNCT03997370Written as Iohexol
- Comparison of CE-DBT and MRI in Patients With Known Breast LesionsTerminatedEarly Phase 1UNC Lineberger Comprehensive Cancer CenterNCT05754749Written as Iohexol 350 Mg/mL Injectable Solution
- Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal FailureCompletedPhase 3University Hospital, AngersNCT02961478Written as IOHEXOL
- Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended LymphadenectomyCompletedPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT06820320Written as oral iohexol
- Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine ClearanceCompletedNot applicableAssistance Publique - Hôpitaux de ParisNCT04776486Written as Iohexol
- Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility StudyCompletedPhase 3University Hospital, ToursNCT02050269Written as Iohexol
- IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in RadiotherapyTerminatedEarly Phase 1Columbia UniversityNCT04199754Written as Omnipaque 300mg/mL Solution for Injection
- Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color TypesCompletedPhase 2MediBeaconNCT02772276Written as Iohexol
- Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic ComparisonCompletedNot applicableUniversity of NebraskaNCT00626366Written as Omnipaque 240 mg I/mL
- Pediatric Risk of Hypothyroidism With Iodinated Contrast MediaWithdrawnPhase 4GE HealthcareNCT03631771Written as Iohexol
- A Study of the Effect of Abemaciclib on Metformin and Iohexol in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT02884089Written as Iohexol
- Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management ProtocolWithdrawnNot applicableThe Guthrie ClinicNCT02928458Written as Omnipaque
- Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CTCompletedPhase 4University of Alabama at BirminghamNCT00478556Written as Omnipaque
- Measurement of Glomerular Filtration Rate (GFR) in HIV Patients: Single-center Study Comparing the Accuracy of Estimators of GFR Versus Iohexol Plasma ClearanceCompletedPhase 4Centre Hospitalier Universitaire de Saint EtienneNCT02522338Written as iohexol
- A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy SubjectsCompletedPhase 1ViiV HealthcareNCT01214993Written as Iohexol Injection
Given in every arm · 3 — Iohexol is usual care beside what is tested
- Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast CancerTerminatedPhase 1Jennifer Lee Caswell-JinNCT04504331Written as Omnipaque 350
- Effect of Evolocumab on Coronary AtherosclerosisCompletedPhase 3Cedars-Sinai Medical CenterNCT03689946Written as Omnipaque
- Comparison of Vascular Access for Radial and Femoral Completion of Diagnostic Cardiac CatheterizationCompletedPhase 3Centro Cardiológico del Caribe, ColumbiaNCT01984411Written as Omnipaque
Codes
What other systems call Iohexol · ClinicalTrials.gg INT007681
- MeSH (NLM) D007472IohexolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 4419T9MX03IOHEXOLConfirmed FDA, NLM, Wikidata
- RxNorm 5956Confirmed FDA, Wikidata
- Wikidata Q410683iohexolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65939IohexolOne source FDA
- DrugBank DB01362One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007472 | Iohexol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 4419T9MX03 | IOHEXOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 5956 | — | Confirmed FDA, Wikidata |
| Wikidata | Q410683 | iohexol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65939 | Iohexol | One source FDA |
| DrugBank | DB01362 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.